Commensal bacteria
|
Commensal bacteria |
Anti-inflammatory activity |
miR-10a |
DCs |
Negatively regulates host miR-10a expression, which contribute to the intestinal homeostasis maintenance by targeting IL-12/IL-23p40 expression |
C57BL/6 (B6) mice |
Xue X, et al. (2011) [125] |
Commensal flora |
Proinflammatory activity |
miR-107 |
DCs and macrophages |
Downregulates miR-107 expression, known to represses the expression of IL-23p19, thereby favouring IL-23 expression |
IECs, lamina propria CD11c+ myeloid cells including dendritic cells and macrophages, and T cells; DSS-induced colitis in mice |
Xue X, et al. (2014) [126] |
Commensal bacteria |
Anti-inflammatory activity |
miR-10a |
DCs |
Inhibits human DCs miR-10a expression, which downregulates mucosal inflammatory response through inhibition of IL-12/IL-23p40 and NOD2 expression, and blockade of Th1/Th17 cell immune responses |
Human monocyte-derived dendritic cells |
Wu W, et al. (2015) [127] |
Commensal microbiome-dependent (Bacteroides acidifaciens and Lactobacillus johnsonii
|
Anti-inflammatory activity |
miR-21-5p |
IECs |
Commensal microbiome-dependent miR-21-5p expression in IECs regulates intestinal epithelial permeability via ADP Ribosylation Factor 4 (ARF4) |
HT-29 and Caco-2 cells |
Nakata K., et al. (2017) [128] |
Cluster(s)
|
↓ of Bacteroidetes and ↑ of protective Firmicutes and Clostridia
|
Anti-inflammatory activity |
miR-21 |
Colonic mucosae |
Leads to miR-21 reduction, known to influence the pathogenesis of intestinal inflammation by causing propagation of a disrupted gut microbiota |
WT and miR-21−/− mice |
Johnston DGW, et al. (2018) [129] |
Cluster enriched in Bacteroides fragilis
|
- |
DNA methylation |
Intestinal mucosa |
Induces 33 and 19 significantly hyper-methylated or hypomethylated sites, including hyper-methylated signals in the gene body of Notch Receptor 4 (NOTCH4) |
50 CD; 80 UC; 31 controls |
Ryan FJ, et al. (2020) [130] |
Cluster enriched in Escherichia/Shigella/Klebsiella and Ruminococcus gnavus
|
Proinflammatory activity |
DNA methylation |
Intestinal mucosa |
Larger number of differentially methylated CpG sites (131 hyper- and 475 hypomethylated), including hypomethylation in CCDC88B (recently correlated with risk of CD) and Transporter 2 (TAP2), involved in genetic heterogeneity of CD |
Cluster enriched in B. vulgatus
|
- |
DNA methylation |
Intestinal mucosa |
Induces 23 hyper- and 18 hypomethylated sites, significant hyper-methylation was observed in the gene body of DNA Damage Regulated Autophagy Modulator 1 (DRAM1) |
Specific germ
|
Adherent-invasive Escherichia coli (AIEC)
|
Proinflammatory activity |
miR-30c and miR-130a |
IECs |
Upregulates levels of miR-30c and miR-130a in IECs (by activating NF-κB), reducing the levels of ATG5 and ATG16L1 and inhibiting autophagy, leading to increased numbers of intracellular AIEC and an increased inflammatory response |
Cultured IECs and mouse enterocytes |
Nguyen HT, et al. (2014) [115] |
AIEC
|
Proinflammatory activity |
let-7b |
IECs |
Instigates excessive mucosal immune response against gut microbiota via miR let-7b/TLR4 signaling pathway |
WT and IL-10 KO mice; T84 cells |
Guo Z, et al. (2018) [117] |
AIEC
|
Proinflammatory activity |
miR-30c and miR-130a |
IECs |
AIEC-infected IECs secretes exosomes that can transfer specific miRs (miR-30c and miR-130a) to recipient IECs, inhibiting autophagy-mediated clearance of intracellular AIEC
|
T84 cells |
Larabi A, et al. (2020) [116] |
Mycobacterium avium subspecies paratuberculosis (MAP)
|
Proinflammatory activity |
miR-21 |
Macrophages |
MAP upregulates miR-21 in macrophages, a change that results in diminished macrophages clearance ability and favours pathogens survival within the cells |
THP-1 cells |
Mostoufi-Afshar S, et al. (2018) [119] |
Lactobacillus rhamnosus GG
|
Anti-inflammatory activity |
miR-146a and miR-155 |
DCs |
Induces a significant downregulation of miR-146a expression, a negative regulator of immune response, and upupregulation of on miR-155 |
Cultured DCs |
Giahi L., et al. (2012) |
Lactobacillus acidophilus
|
Anti-inflammatory activity |
miRs |
Colonic mucosae |
L. acidophilus induce miRs expression |
DSS-induced colitis in mice |
Kim WK, et al. (2021) [131] |
Faecalibacterium prausnitzii |
Anti-inflammatory activity |
HDAC1 inhibition |
T cells |
Inhibits HDAC1, promotes Foxp3 and blocks the IL-6/STAT3/IL-17 downstream pathway contributing to the maintain of Th17/Treg balance |
IBD patients (n = 9) and healthy control (n = 6); DSS-induced colitis in mice |
Zhou L, et al. (2018) [132] |
Faecalibacterium prausnitzii |
Anti-inflammatory activity |
HDAC3 inhibition |
T cells |
Produces butyrate to decrease Th17 differentiation and attenuate colitis through inhibiting HDAC3 and c-Myc-related metabolism in T cells |
IBD patients; TNBS-induced colitis in mice |
Zhang M, et al. (2019) [133] |
Trichinella spiralis
|
Anti-inflammatory activity |
miRs |
T cells |
Extra-vesicles-derived miR are involved in the regulation of the host immune response, including inflammation, including increase of Th2 and Treg cells |
TNBS-induced colitis in mice |
Yang Y, et al. (2020) [134] |
Enterotoxigenic Bacteroides fragilis (ETBF)
|
Proinflammatory activity |
miR-149-3p |
T cells |
Downregulates miR-149-3p, which play a role in modulation of T-helper type 17 cell differentiation (with increased number of T-helper type 17 cell contributing to intestinal inflammation) |
ETBF cells |
Cao Y, et al. (2021) [135] |
Bacterial component
|
Roseburia intestinalis-derived flagellin |
Anti-inflammatory activity |
lncRNA |
IECs |
Flagellin induces p38-stat1 activation, activated HIF1A-AS2 promotor, induced HIF1A-AS2 (a lncRNA) expression in gut epithelium in a dose- and time-dependent manner. HIF1A-AS2 inactivates NF-κB/Jnk pathway and thus inhibits inflammatory responses |
DSS/Flagellin-challenged mice; Caco-2 cells |
Quan Y, et al. (2018) [124] |
Roseburia intestinalis-derived flagellin |
Anti-inflammatory activity |
miR-223-3p |
Macrophages |
Flagellin inhibited activation of the NLRP3 inflammasome and pyroptosis via miR-223-3p/NLRP3 signaling in macrophages |
DSS-induced colitis model in C57Bl/6 mice and the LPS/ATP-induced THP-1 macrophages |
Wu X, et al. (2020) [123] |
LPS |
Proinflammatory activity |
H3K4me1, H3K4me3, and H3K27ac histone |
Macrophages |
Increases H3K4me1, H3K4me3, and H3K27ac histone marks, particularly in genes associated with an inflammatory response such as IL-12a and IL-18 |
IL-10-deficient (Il10(−/−)) mice |
Simon JM, et al. (2016) [136] |
LPS and flagellin |
Anti-inflammatory activity |
miR-146 |
IECs |
Stimulate miR-146a overexpression in IECs, induces immune tolerance, inhibiting cytokine production (MCP-1 and GROα/IL-8) |
TNBS and DSS-induced colitis in mice |
Anzola A, et al. (2018) [137] |
LPS |
Proinflammatory activity |
lncRNA H19 |
IECs |
Increases levels of H19 lncRNA in epithelial cells in the intestine. H19 lncRNA bound to p53 and miR (miR-34a and let-7) that inhibit cell proliferation (alters regeneration of the epithelium) |
Intestinal tissues of UC patients and mice |
Geng H, et al. (2018) [138] |
LPS |
Proinflammatory activity |
miR-19b |
IECs |
LPS significantly induces cell inflammatory injury, downregulated miR-19b expression and activates NF-κB and PI3K/AKT pathway |
Caco2 cells |
Qiao CX, et al. (2018) [120] |
LPS |
Proinflammatory activity |
lncRNA |
Monocytes/macrophages |
LPS promotes a downregulation of the lncRNA growth arrest-specific transcript 5 (GAS5), could mediate tissue damage by modulating the expression of matrix metalloproteinases |
IBD patients (n = 25) |
Lucafò M, et al. (2019) [139] |
LPS |
Proinflammatory activity |
miR-215 |
Fibroblasts |
LPS upregulates the expression of miR-215, increases oxidative stress in LPS-treated intestinal fibroblast by downregulating GDF11 (Growth differentiation factor 11) expression and activating the TLR4/NF-κB and JNK/p38 signaling pathways |
CCD-18Co cells |
Sun B, et al. (2020) [122] |
LPS |
Proinflammatory activity |
miR-506 and DNMT1 modification |
IECs |
LPS inhibits miR-506, leading to reduced expression of anion exchange protein 2 and inositol-1,4,5-trisphosphate-receptor but was accompanied by a substantial increase in DNMT1 and SPHK1 (sphingosine kinase 1) expression. The enhanced levels of kinase SPHK1 resulte in upregulation of bioactive sphingosine-1-phosphate (S1P) which led to further activation of S1P-dependent signaling pathways. The net effect of these responses is severe inflammation |
Patients with PSC, PSC with concurrent UC (PSC + UC), UC alone, and healthy controls (n = 10 each); Caco2 cells |
Kempinska-Podhorodecka A, et al. (2021) [140] |
LPS |
Proinflammatory activity |
miR-497 |
Macrophages |
Reduces miR-497, promotes the activation of NF-κB pathway and the release of cytokines |
IBD patients, mice with colitis and LPS-treated RAW264.7 cells |
Zhang M, et al. (2021) [121] |